Natural/organic in the EU
This article was originally published in The Rose Sheet
Executive Summary
Sales of natural and organic cosmetics continue to grow healthily in Europe, but the sector is crowding, Organic Monitor indicates in Sept. 29 release announcing availability of new report. Increasingly firms will have to differentiate their products from the competition and focus on specific consumer groups or sales channels, research and consulting firm says. Natural/organic businesses are growing particularly fast in France and Germany, with a growing number of mainstream retailers stocking their shelves with "chemically clean" and ethical options. Meanwhile, private-label natural/organic offerings are on the rise in supermarkets, drugstores, organic food stores and other retailers and account for more than 10 percent of total sales in the category in Germany, Organic Monitor notes. The UK natural/organic market is performing less vigorously, with sales growth declining from 16 percent in 2008 to 8 percent in 2009. Across Europe, however, the natural/organic space will advance 13 percent to roughly $2.48 billion this year, nearing $2.91 billion in 2010 and constituting 10 percent of the total cosmetics market "in the coming years," owing largely to rocketing growth in Germany, Organic Monitor predicts. Currently about 3 percent of the market belongs to natural/organic products. Certification is expected to pick up, particularly with launch of the COSMOS standard
You may also be interested in...
NaTrue Extends Certification To Raw Materials Suppliers, Launches Database
Brussels-based natural products certifier NaTrue is opening its certification process to raw materials manufacturers and compiling authenticated substances in an online database that will benefit both suppliers and their customers, it says
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.